Many elements of President Donald Trump's plan to lower drug costs have been blocked by courts, dropped by the administration or delayed, which is causing frustration for the president, according to The Wall Street Journal.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,